ValitaCell has collaborated with life science giant Tecan on several projects in the recent past and we were delighted to be asked to feature in Tecan’s latest journal. Published a number of times a year, Tecan seek to share users experiences and developments from peers in clinical diagnostics, research and life sciences.
Business Development Manager, Dr. Eligio Iannetti, was interviewed for the latest journal where he outlined ValitaCell’s goal to improve speed and accuracy in the biopharmaceutical industry. Eligio outlined the role that our innovative technologies including Quantum, ChemStress and CellAi can play in improving the workflows for our client companies.
Read the full interview in Tecan’s journal here